PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Enzyme revealed as promising target to treat asthma and cancer

2014-04-10
(Press-News.org) In experiments with mice, Johns Hopkins Kimmel Cancer Center scientists have identified an enzyme involved in the regulation of immune system T cells that could be a useful target in treating asthma and boosting the effects of certain cancer therapies.

In research described online April 6 in Nature Immunology, the investigators show that mice without the enzyme SKG1 were resistant to dust mite-induced asthma. And mice with melanoma and missing the enzyme, developed far fewer lung tumors—less than half as many—than mice with SKG1.

"If we can develop a drug that blocks the enzyme in a way that mimics what happens when the enzyme is missing, we would not only have a treatment to inhibit asthma, but also a drug that could be used in conjunction with other experimental therapies aimed at helping the immune system fight cancer," said Jonathan D. Powell, M.D., professor of oncology at the Johns Hopkins Kimmel Cancer Center.

The unusual dual potential of an SKG1-blocking compound stems from the enzyme's role in a key pathway linked to T cells, which act as either "generals" of the immune system by directing how the system works, or "soldiers" that seek and destroy foreign cells.

Powell and his colleagues decided to look at SKG1 because it works along the same pathway of a protein called mTOR, a focus of their previous research. The mTOR pathway helps T cells decipher signals from their environment, and prompts the cells to transform into specific T cell types.

As part of this pathway, SKG1 dials down production of a signaling protein called interferon-gamma. When SKG1 is inactive, T cells produce increased amounts of interferon-gamma that appear to be useful in fighting tumor cells.

Powell said that a SKG1-blocking drug might be used in conjunction with other cancer immunotherapies as a sort of booster medication to enhance their effects. Experimental cancer immunotherapies, including vaccines and so-called checkpoint blockade inhibitors, are the focus of intense research within the past few years, he added.

The researchers also discovered that SKG1 promotes the production of T helper 2 cells, which become overactive in asthma and other allergies in a sort of runaway case of inflammation. Finding a drug that could shut down SKG1 could help block the inflammation that causes asthma and other allergic reactions.

By untangling the different effects of SKG1, Powell said, his team has advanced efforts to fine-tune immune responses in patients. "We're not suppressing or exacerbating the immune system, we're regulating it," he noted. "We're regulating it to do exactly what we want it to do."

INFORMATION:

Other scientists involved in the study were Emily Heikamp, Chirag H. Patel, Sam Collins, Adam Waickman, Min-Hee Oh, Im-Hong Sun, Peter Illei and Maureen R. Horton from Johns Hopkins; Archna Sharma and Jyoti Sen from the National Institutes of Health; and Aniko Naray-Fejes-Toth and Geza Fejes-Toth from Dartmouth Medical School.

The work was supported by the National Institutes of Health (R01 AI77610, DK 41481, DK 58898); the American Asthma Foundation; the American Medical Association Seed Foundation Grant; and the Flight Attendant Medical Research Institute.

On the Web: Nature Immunology

JOHNS HOPKINS MEDICINE

Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is a $6.7 billion integrated global health enterprise and one of the leading health care systems in the United States. JHM unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. JHM's mission is to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. Diverse and inclusive, JHM educates medical students, scientists, health care professionals and the public; conducts biomedical research; and provides patient-centered medicine to prevent, diagnose and treat human illness. JHM operates six academic and community hospitals, four suburban health care and surgery centers, more than 38 primary health care outpatient sites and other businesses that care for national and international patients and activities. The Johns Hopkins Hospital, opened in 1889, was ranked number one in the nation for 21 years by U.S. News & World Report.

Media Contacts:
Vanessa Wasta, 410-614-2916, wasta@jhmi.edu
Amy Mone, 410-614-2915, amone@jhmi.edu


ELSE PRESS RELEASES FROM THIS DATE:

Researchers discover possible new target to attack flu virus

Researchers discover possible new target to attack flu virus
2014-04-10
Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus. Better antiviral drugs could help the millions of people annually infected by flu, which kills up to 500,000 people each year. When an influenza virus infects a human cell, it uses some of the host's cellular machinery to make copies of itself, or replicate. In this study, the researchers ...

For sick, elderly patients, surgical decision making 'takes a village'

2014-04-10
Surgical decision making for sick, elderly patients should be orchestrated by a multidisciplinary team, including the patient, his or her family, the surgeon, primary care physician, nurses and non-clinicians, such as social workers, advocates Laurent G. Glance, M.D., in a perspective piece published in the New England Journal of Medicine. For this group of patients, surgery can be very risky. Glance, professor and vice-chair for research in the Department of Anesthesiology at the University of Rochester School of Medicine and Dentistry believes a more patient-centered, ...

Medicare's flawed adjustment methodology poor way to spend billions

2014-04-10
Lebanon, N.H. (April 10, 2014) – The methodology Medicare uses to adjust the billions of dollars it pays health plans and hospitals to account for how sick their patients are is flawed and should be replaced, according to a new study by Dartmouth investigators published in the journal BMJ that weighed the performance of Medicare's methodology against alternatives. The researchers from the Dartmouth Atlas Project compared Medicare's current risk-adjustment methodology, which is based on the diagnoses recorded in patients' claims records, against adjustment indices based ...

American College of Physicians releases policy paper on medical liability crisis

2014-04-10
Washington, DC, April 10, 2014 -- The American College of Physicians (ACP) today released a policy paper on the medical liability crisis, which continues to have a profound effect on the medical system. "Medical Liability Reform—Innovative Solutions for a New Health Care System" provides an update of the medical liability landscape, state-based activity on medical liability reform, and summarizes traditional and newer reform proposals and their ability to affect system efficiency and encourage patient safety. "While medical liability premiums have leveled off in the ...

New cell models for tracking body clock gene function will help find novel meds

2014-04-10
PHILADELPHIA — The consequences of modern life -- shift work, cell phone addiction, and travel across time zones -- all disturb internal clocks. These are found in the brain where they regulate sleep and throughout the body where they regulate physiology and metabolism. Disrupting the clocks is called circadian misalignment, which has been linked to metabolic problems, even in healthy volunteers. Researchers from the Perelman School of Medicine at the University of Pennsylvania and the University of Memphis describe in PLOS Genetics the development of new cell models ...

Tumor-suppressor connects with histone protein to hinder gene expression

Tumor-suppressor connects with histone protein to hinder gene expression
2014-04-10
HOUSTON -- A tumor-suppressing protein acts as a dimmer switch to dial down gene expression. It does this by reading a chemical message attached to another protein that's tightly intertwined with DNA, a team led by scientists at The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2014. The findings, also published in the journal Nature on April 10, provide evidence in support of the "histone code" hypothesis. The theory holds that histone proteins, which combine with DNA to form chromosomes, are more intimately involved in gene expression ...

Study shows 'dinosaurs of the turtle world' at risk in Southeast rivers

2014-04-10
GAINESVILLE, Fla. --- Conservation of coastal rivers of the northern Gulf of Mexico is vital to the survival of the alligator snapping turtle, including two recently discovered species, University of Florida scientists say. A new study appearing this week in the journal Zootaxa shows the alligator snapping turtle, the largest freshwater turtle in the Western Hemisphere and previously believed to be one species, is actually three separate species. The limited distribution of the species, known to weigh as much 200 pounds, could potentially affect the conservation of ...

How widespread is tax evasion?

2014-04-10
Tax evasion is widely assumed to be an eternal problem for governments — but how widespread is it? For the first time, a new study, co-authored by an MIT professor, has put a cost on a particular kind of tax evasion, known as "round-tripping," that the U.S. government has been trying to thwart. In round-tripping, U.S. investors move funds to offshore tax havens, then invest in U.S. equity and debt markets with these "foreign" funds. In essence, the U.S. investors are disguising themselves as foreign investors, who are not subject to the same tax rates on capital gains ...

World ranking tracks evoluntionary distinctness of birds

2014-04-10
A team of international scientists, including a trio from Simon Fraser University, has published the world's first ranking of evolutionary distinct birds under threat of extinction. These include a cave-dwelling bird that is so oily it can be used as a lamp and a bird that has claws on its wings and a stomach like a cow. The research, published today in Current Biology, the shows that Indonesia, Australia and New Zealand all score high on responsibility for preserving irreplaceable species. The researchers examined nearly 10,000 bird species and identified more than 100 ...

Insights into how a bird flu virus spreads could prevent pandemics

2014-04-10
The H5N1 bird flu virus has infected and killed hundreds of people, despite the fact that, at the moment, the virus can't spread easily between people. The death toll could become much worse if the virus became airborne. A study published by Cell Press April 10th in the journal Cell has revealed a minimal set of mutations allowing H5N1 to be transmitted through the air from one ferret to another. The findings will be invaluable for future surveillance programs and may provide early warning signals of the emergence of potential pandemic strains. "By gaining fundamental ...

LAST 30 PRESS RELEASES:

Study reveals insights about brain regions linked to OCD, informing potential treatments

Does ocean saltiness influence El Niño?

2026 Young Investigators: ONR celebrates new talent tackling warfighter challenges

Genetics help explain who gets the ‘telltale tingle’ from music, art and literature

Many Americans misunderstand medical aid in dying laws

Researchers publish landmark infectious disease study in ‘Science’

New NSF award supports innovative role-playing game approach to strengthening research security in academia

Kumar named to ACMA Emerging Leaders Program for 2026

AI language models could transform aquatic environmental risk assessment

New isotope tools reveal hidden pathways reshaping the global nitrogen cycle

Study reveals how antibiotic structure controls removal from water using biochar

Why chronic pain lasts longer in women: Immune cells offer clues

Toxic exposure creates epigenetic disease risk over 20 generations

More time spent on social media linked to steroid use intentions among boys and men

New study suggests a “kick it while it’s down” approach to cancer treatment could improve cure rates

Milken Institute, Ann Theodore Foundation launch new grant to support clinical trial for potential sarcoidosis treatment

New strategies boost effectiveness of CAR-NK therapy against cancer

Study: Adolescent cannabis use linked to doubling risk of psychotic and bipolar disorders

Invisible harms: drug-related deaths spike after hurricanes and tropical storms

Adolescent cannabis use and risk of psychotic, bipolar, depressive, and anxiety disorders

Anxiety, depression, and care barriers in adults with intellectual and developmental disabilities

Study: Anxiety, gloom often accompany intellectual deficits

Massage Therapy Foundation awards $300,000 research grant to the University of Denver

Gastrointestinal toxicity linked to targeted cancer therapies in the United States

Countdown to the Bial Award in Biomedicine 2025

Blood marker from dementia research could help track aging across the animal world

Birds change altitude to survive epic journeys across deserts and seas

Here's why you need a backup for the map on your phone

ACS Central Science | Researchers from Insilico Medicine and Lilly publish foundational vision for fully autonomous “Prompt-to-Drug” pharmaceutical R&D

Increasing the number of coronary interventions in patients with acute myocardial infarction does not appear to reduce death rates

[Press-News.org] Enzyme revealed as promising target to treat asthma and cancer